Switch theme
Sign up to access all valuation multiples
Youcare Pharmaceutical Group Co Ltd is a pharmaceutical group enterprise integrating new drug research and development, drug production, circulation and sales.
2001
n/a
Last FY Revenue $525M
Last FY EBITDA $53.1M
$759M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Youcare Pharmaceutical achieved revenue of $525M and an EBITDA of $53.1M.
Youcare Pharmaceutical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Youcare Pharmaceutical valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $525M | XXX | XXX | XXX |
| Gross Profit | XXX | $303M | XXX | XXX | XXX |
| Gross Margin | XXX | 58% | XXX | XXX | XXX |
| EBITDA | XXX | $53.1M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 10% | XXX | XXX | XXX |
| EBIT | XXX | $35.5M | XXX | XXX | XXX |
| EBIT Margin | XXX | 7% | XXX | XXX | XXX |
| Net Profit | XXX | $17.2M | XXX | XXX | XXX |
| Net Margin | XXX | 3% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Youcare Pharmaceutical's stock price is CNY 14 (or $2).
Youcare Pharmaceutical has current market cap of CNY 6.3B (or $870M), and EV of CNY 5.5B (or $759M).
See Youcare Pharmaceutical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $759M | $870M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Youcare Pharmaceutical has market cap of $870M and EV of $759M.
Youcare Pharmaceutical's trades at 1.4x EV/Revenue multiple, and 14.3x EV/EBITDA.
Equity research analysts estimate Youcare Pharmaceutical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Youcare Pharmaceutical's P/E ratio is not available.
See valuation multiples for Youcare Pharmaceutical and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $870M | XXX | $870M | XXX | XXX | XXX |
| EV (current) | $759M | XXX | $759M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 14.3x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 21.4x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 50.7x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 68.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialYoucare Pharmaceutical's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Youcare Pharmaceutical's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Youcare Pharmaceutical's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Youcare Pharmaceutical and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 10% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 33% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 10% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 51% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Youcare Pharmaceutical acquired XXX companies to date.
Last acquisition by Youcare Pharmaceutical was XXXXXXXX, XXXXX XXXXX XXXXXX . Youcare Pharmaceutical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Youcare Pharmaceutical founded? | Youcare Pharmaceutical was founded in 2001. |
| Where is Youcare Pharmaceutical headquartered? | Youcare Pharmaceutical is headquartered in China. |
| Is Youcare Pharmaceutical publicy listed? | Yes, Youcare Pharmaceutical is a public company listed on SHG. |
| What is the stock symbol of Youcare Pharmaceutical? | Youcare Pharmaceutical trades under 688658 ticker. |
| When did Youcare Pharmaceutical go public? | Youcare Pharmaceutical went public in 2020. |
| Who are competitors of Youcare Pharmaceutical? | Similar companies to Youcare Pharmaceutical include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Youcare Pharmaceutical? | Youcare Pharmaceutical's current market cap is $870M |
| Is Youcare Pharmaceutical profitable? | Yes, Youcare Pharmaceutical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
